Literature DB >> 23787999

Akt1 is the principal Akt isoform regulating apoptosis in limiting cytokine concentrations.

B D Green1, A M Jabbour, J J Sandow, C D Riffkin, D Masouras, C P Daunt, M Salmanidis, G Brumatti, B A Hemmings, M A Guthridge, R B Pearson, P G Ekert.   

Abstract

The activation of the Akt signalling in response to cytokine receptor signalling promotes protein synthesis, cellular growth and proliferation. To determine the role of Akt in interleukin-3 (IL-3) signalling, we generated IL-3-dependent myeloid cell lines from mice lacking Akt1, Akt2 or Akt3. Akt1 deletion resulted in accelerated apoptosis at low concentrations of IL-3. Expression of constitutively active Akt1 was sufficient to delay apoptosis in response to IL-3 withdrawal, but not sufficient to induce proliferation in the absence of IL-3. Akt1 prolonged survival of Bim- or Bad-deficient cells, but not cells lacking Puma, indicating that Akt1-dependent repression of apoptosis was in part dependent on Puma and independent of Bim or Bad. Our data show that a key role of Akt1 during IL-3 signalling is to repress p53-dependent apoptosis pathways, including transcriptional upregulation of Puma. Moreover, our data indicate that regulation of BH3-only proteins by Akt is dispensable for Akt-dependent cell survival.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23787999      PMCID: PMC3770321          DOI: 10.1038/cdd.2013.63

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  38 in total

1.  Bad-deficient mice develop diffuse large B cell lymphoma.

Authors:  Ann M Ranger; Jiping Zha; Hisashi Harada; Sandeep Robert Datta; Nika N Danial; Andrew P Gilmore; Jeffery L Kutok; Michelle M Le Beau; Michael E Greenberg; Stanley J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-22       Impact factor: 11.205

2.  Cell death in the absence of Bax and Bak.

Authors:  T Lindsten; C B Thompson
Journal:  Cell Death Differ       Date:  2006-05-05       Impact factor: 15.828

3.  Cell death provoked by loss of interleukin-3 signaling is independent of Bad, Bim, and PI3 kinase, but depends in part on Puma.

Authors:  Paul G Ekert; Anissa M Jabbour; Anand Manoharan; Jacki E Heraud; Jai Yu; Miha Pakusch; Ewa M Michalak; Priscilla N Kelly; Bernard Callus; Thomas Kiefer; Anne Verhagen; John Silke; Andreas Strasser; Christoph Borner; David L Vaux
Journal:  Blood       Date:  2006-05-16       Impact factor: 22.113

4.  Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1.

Authors:  Ulrich Maurer; Céline Charvet; Allan S Wagman; Emmanuel Dejardin; Douglas R Green
Journal:  Mol Cell       Date:  2006-03-17       Impact factor: 17.970

5.  Glycogen synthase kinase 3alpha and 3beta mediate a glucose-sensitive antiapoptotic signaling pathway to stabilize Mcl-1.

Authors:  Yuxing Zhao; Brian J Altman; Jonathan L Coloff; Catherine E Herman; Sarah R Jacobs; Heather L Wieman; Jessica A Wofford; Leah N Dimascio; Olga Ilkayeva; Ameeta Kelekar; Tannishtha Reya; Jeffrey C Rathmell
Journal:  Mol Cell Biol       Date:  2007-03-19       Impact factor: 4.272

6.  Quantitative analysis of anti-apoptotic function of Akt in Akt1 and Akt2 double knock-out mouse embryonic fibroblast cells under normal and stressed conditions.

Authors:  Xuesong Liu; Yan Shi; Morris J Birnbaum; Keqiang Ye; Ron De Jong; Tillman Oltersdorf; Vincent L Giranda; Yan Luo
Journal:  J Biol Chem       Date:  2006-08-21       Impact factor: 5.157

7.  Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice.

Authors:  H Cho; J L Thorvaldsen; Q Chu; F Feng; M J Birnbaum
Journal:  J Biol Chem       Date:  2001-08-31       Impact factor: 5.157

8.  Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis.

Authors:  Tanya M Gottlieb; Juan Fernando Martinez Leal; Rony Seger; Yoichi Taya; Moshe Oren
Journal:  Oncogene       Date:  2002-02-14       Impact factor: 9.867

9.  BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes.

Authors:  Philippe Bouillet; Jared F Purton; Dale I Godfrey; Li-Chen Zhang; Leigh Coultas; Hamsa Puthalakath; Marc Pellegrini; Suzanne Cory; Jerry M Adams; Andreas Strasser
Journal:  Nature       Date:  2002-02-21       Impact factor: 49.962

10.  Constitutive phosphoinositide 3-kinase/Akt activation represents a favorable prognostic factor in de novo acute myelogenous leukemia patients.

Authors:  Jerome Tamburini; Caroline Elie; Valérie Bardet; Nicolas Chapuis; Sophie Park; Philippe Broët; Pascale Cornillet-Lefebvre; Bruno Lioure; Valérie Ugo; Odile Blanchet; Norbert Ifrah; Francis Witz; François Dreyfus; Patrick Mayeux; Catherine Lacombe; Didier Bouscary
Journal:  Blood       Date:  2007-04-10       Impact factor: 22.113

View more
  16 in total

1.  Loss of 2 Akt (Protein Kinase B) Isoforms in Hematopoietic Cells Diminished Monocyte and Macrophage Survival and Reduces Atherosclerosis in Ldl Receptor-Null Mice.

Authors:  Vladimir R Babaev; Lei Ding; Youmin Zhang; James M May; Stephen A Ramsey; Kasey C Vickers; MacRae F Linton
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-02       Impact factor: 8.311

2.  Urinary bladder organ hypertrophy is partially regulated by Akt1-mediated protein synthesis pathway.

Authors:  Li-Ya Qiao; Chunmei Xia; Shanwei Shen; Seong Ho Lee; Paul H Ratz; Matthew O Fraser; Amy Miner; John E Speich; Jeffrey J Lysiak; William D Steers
Journal:  Life Sci       Date:  2018-03-21       Impact factor: 5.037

3.  AKT Isoforms in Macrophage Activation, Polarization, and Survival.

Authors:  Ioanna Lapi; Maria G Daskalaki; Konstantinos Axarlis; Eleni Paflioti; Philip N Tsichlis; Eleni Vergadi; Christos Tsatsanis
Journal:  Curr Top Microbiol Immunol       Date:  2022       Impact factor: 4.737

Review 4.  Phosphoinositide 3-kinase/Akt and its related signaling pathways in the regulation of tumor-associated macrophages polarization.

Authors:  Depeng Yang; Lijun Yang; Jialing Cai; Huaxin Li; Zheng Xing; Ying Hou
Journal:  Mol Cell Biochem       Date:  2022-05-19       Impact factor: 3.842

5.  Graph theoretic network analysis reveals protein pathways underlying cell death following neurotropic viral infection.

Authors:  Sourish Ghosh; G Vinodh Kumar; Anirban Basu; Arpan Banerjee
Journal:  Sci Rep       Date:  2015-09-25       Impact factor: 4.379

6.  Protein Phosphatase 1 Regulatory Subunit SDS22 Inhibits Breast Cancer Cell Tumorigenesis by Functioning as a Negative Regulator of the AKT Signaling Pathway.

Authors:  Debasish Paul; Anil Bapu Bargale; Srikanth Rapole; Praveen Kumar Shetty; Manas Kumar Santra
Journal:  Neoplasia       Date:  2018-11-27       Impact factor: 5.715

7.  Isoform-Specific Role of Akt in Oral Squamous Cell Carcinoma.

Authors:  Nand Kishor Roy; Javadi Monisha; Ganesan Padmavathi; H Lalhruaitluanga; Nachimuthu Senthil Kumar; Anuj Kumar Singh; Devivasha Bordoloi; Munindra Narayan Baruah; Gazi Naseem Ahmed; Imliwati Longkumar; Frank Arfuso; Alan Prem Kumar; Ajaikumar B Kunnumakkara
Journal:  Biomolecules       Date:  2019-06-27

8.  Cyclooxygenase-2 inhibitor is a robust enhancer of anticancer agents against hepatocellular carcinoma multicellular spheroids.

Authors:  Jie Cui; Ya-Huan Guo; Hong-Yi Zhang; Li-Li Jiang; Jie-Qun Ma; Wen-Juan Wang; Min-Cong Wang; Cheng-Cheng Yang; Ke-Jun Nan; Li-Ping Song
Journal:  Onco Targets Ther       Date:  2014-02-24       Impact factor: 4.147

9.  Synergistic effect of combinatorial treatment with curcumin and mitomycin C on the induction of apoptosis of breast cancer cells: a cDNA microarray analysis.

Authors:  Qian-Mei Zhou; Qi-Long Chen; Jia Du; Xiu-Feng Wang; Yi-Yu Lu; Hui Zhang; Shi-Bing Su
Journal:  Int J Mol Sci       Date:  2014-09-15       Impact factor: 5.923

10.  Differential regulation of AKT1 contributes to survival and proliferation in hepatocellular carcinoma cells by mediating Notch1 expression.

Authors:  Jing Chen; Jun Liang; Shihai Liu; Shanai Song; Wenxuan Guo; Fangzhen Shen
Journal:  Oncol Lett       Date:  2018-03-07       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.